‘Asia Pacific is fast emerging as one of the major hubs in terms of miRNA research’, says RNCOS.
Noida, UP -- (SBWIRE) -- 01/02/2015 -- Capitalizing on its intellectual resources to spearhead the biomedical research industry, the Asia Pacific market for miRNA is expected to grow to US$ 58 Million by 2018. Most of the ongoing studies in Asia Pacific are based on various types of cancer, with main focus on Colorectal Cancer followed closely by Thyroid, Renal, Breast and Lung Cancer. Other major areas of interest in Asia Pacific include Heart diseases, depression, Alzheimer's, Hepatitis and Sepsis. Most of these are diagnostic in nature, and are focused on evaluation of miRNA expression in various types of cancers.
The report "Global miRNA Market Outlook to 2018", covers present and future outlook for the two broad categories of miRNA; the tools and services segments. The former comprises of the various tools that are used to study miRNA. These include isolation kits, PCR arrays, labels, markers, mimics and inhibitors. On the other hand, the latter includes the various services such as purification, expression profiling, quantitation and analysis that are offered by miRNA players. The market has been divided into three sections i.e., The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA.
Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are being applied to control gene translation and consequently its expression.
After an exhaustive study of the industry, RNCOS has laid out the primary market players which engaged in providing miRNA based tools and services. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors. Some of them include Qiagen, Life Technologies, Exiqon and Mirus Bio.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM649.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.